Pathophysiology and management of saphenous vein graft disease

References

• Buxton BF, Galvin SD. The history of arterial revascularization: from Kolesov to Tector and beyond. Ann Cardiothorac Surg. 2013; 2(4):41926–41426. doi: 10.3978/j.issn.2225-319X.2013.07.24
   Google Scholar
• Kunlin J. Le traitement de l’arterite obliterante par la greffe veineuse (1949). Arch Mal Coeur. 1949;42:371–379.
   Google Scholar
• Connolly JE. The history of the in situ saphenous vein bypass. J Vasc Surg. 2011;53(1):241–244. doi: 10.1016/j.jvs.2010.05.018
   PubMed Web of Science ®Google Scholar
• Hall KV. The great saphenous vein used in situ as an arterial shunt after extirpation of the vein valves. A preliminary report. Surgery. 1962;51:492–495.
   PubMed Web of Science ®Google Scholar
• Linton RR, Darling RC. Autogenous saphenous vein bypass grafts in femoropopliteal obliterative arterial disease. Surgery. 1962;51:62–73.
   PubMed Web of Science ®Google Scholar
• Mannick JA, Hume DM. Salvage of extremities by vein grafts in far-advanced peripheral vascular disease. Surgery. 1964;55:154–164.
   PubMed Web of Science ®Google Scholar
• Garrett HE, Dennis EW, DeBakey ME. Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. JAMA. 1973;223(7):792–794. doi: 10.1001/jama.223.7.792
   Google Scholar
• Favaloro RG. Saphenous vein graft in the surgical treatment of coronary artery disease: Operative technique. J Thorac Cardiovasc Surg. 1969;58(2):178–185. doi: 10.1016/S0022-5223(19)42599-3
   PubMed Web of Science ®Google Scholar
• Vineberg A, Munro DD, Cohen H, et al. Four years’ clinical experience with internal mammary artery implantation in the treatment of human coronary artery insufficiency including additional experimental studies. J Thorac Surg. 1955;29(1):1-32. discussion, 32-36. doi: 10.1016/S0096-5588(20)30730-3
   PubMedGoogle Scholar
• Spencer FC, Yong NK, Prachuabmoh K. internal mammary-coronary artery anastomoses performed during cardiopulmonary bypass. J Cardiovasc Surg (Torino). 1964;5:292–297.
   PubMed Web of Science ®Google Scholar
• Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968;5(4):334–339. doi: 10.1016/s0003-4975(10)66351-5
   PubMedGoogle Scholar
• Marti MC, Bouchardy B, Cox JN. Aorto-coronary by-pass with autogenous saphenous vein grafts: histopathological aspects. Virchows Arch A Pathol Pathol Anat. 1971;352(3):255–266. doi: 10.1007/BF00600675
   PubMedGoogle Scholar
• Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1–6. doi: 10.1056/NEJM198601023140101
   PubMed Web of Science ®Google Scholar
• Bakaeen FG, Svensson LG. Why don’t we kill 2 birds with 1 stone? Circulation. 2018; 137(16):1708–1711. doi: 10.1161/CIRCULATIONAHA.117.032885
   PubMedGoogle Scholar
• Goldman S, McCarren M, Sethi GK, et al. Long-term mortality follow-up of radial artery versus saphenous vein in coronary artery bypass grafting: a multicenter, randomized trial. Circulation. 2022;146(17):1323–1325. doi: 10.1161/CIRCULATIONAHA.122.062343
   PubMed Web of Science ®Google Scholar
• Jawitz OK, Lawton JS, Thibault D, et al. Sex differences in coronary artery bypass grafting techniques: a Society of Thoracic Surgeons database analysis. Ann Thorac Surg. 2022;113(6):1979–1988. doi: 10.1016/j.athoracsur.2021.06.039
   PubMed Web of Science ®Google Scholar
• Grondin CM, Thornton JC. The natural history of saphenous vein grafts. In: Lüscher T, Turina M, Braunwald E, editors. Coronary artery graft disease: mechanisms and prevention. Springer; 1994. p. 3–15. doi: 10.1007/978-3-642-78637-2_1
   Google Scholar
• Goldman S, Zadina K, Moritz T, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs cooperative study. J Am Coll Cardiol. 2004;44(11):2149–2156. doi: 10.1016/j.jacc.2004.08.064
   PubMed Web of Science ®Google Scholar
• Tranbaugh RF, Schwann TA, Swistel DG, et al. Coronary artery bypass graft surgery using the radial artery, right internal thoracic artery, or saphenous vein as the second conduit. Ann Thorac Surg. 2017;104(2):553–559. doi: 10.1016/j.athoracsur.2016.11.017
   PubMed Web of Science ®Google Scholar
• Xenogiannis I, Zenati M, Bhatt DL, et al. Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies. Circulation. 2021;144(9):728–745. doi: 10.1161/CIRCULATIONAHA.120.052163
   PubMed Web of Science ®Google Scholar
• Barner HB, Farkas EA. Conduits for coronary bypass: vein grafts. Korean J Thorac Cardiovasc Surg. 2012; 45(5):275–286. doi: 10.5090/kjtcs.2012.45.5.275
   PubMedGoogle Scholar
• Khaleel MS, Dorheim TA, Duryee MJ, et al. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Ann Thorac Surg. 2012;93(2):552–558. doi: 10.1016/j.athoracsur.2011.10.035
   PubMed Web of Science ®Google Scholar
• Foglesong A, Rusia A, Mertens A, et al. Wait for (h)it: immediate and complete bypass graft failure due to heparin induced thrombocytopenia. J Am Coll Cardiol. 2022;79(9_Supplement):2985–2985. doi: 10.1016/S0735-1097(22)03976-6
   Web of Science ®Google Scholar
• Kon ZN, Kwon MH, Collins MJ, et al. Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers. Innov Phila Pa. 2006;1(5):232–238. doi: 10.1097/01.imi.0000242160.21278.b7
   PubMedGoogle Scholar
• Lee S, Lee RT. Mechanical stretch and intimal hyperplasia. Arterioscler Thromb Vasc Biol. 2010;30(3):459–460. doi: 10.1161/ATVBAHA.109.201509
   PubMed Web of Science ®Google Scholar
• Yazdani SK, Farb A, Nakano M, et al. Pathology of drug-eluting versus bare metal stents in saphenous vein bypass graft lesions. JACC: Cardiovasc Interv. 2012;5(6):666–674. doi: 10.1016/j.jcin.2011.12.017
   PubMed Web of Science ®Google Scholar
• Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nature Rev Cardiol. 2016;13:79-98. doi: 10.1038/nrcardio.2015.164.
   Google Scholar
• Shelton ME, Forman MB, Virmani R, et al. A comparison of morphologic and angiographic findings in long-term internal mammary artery and saphenous vein bypass grafts. J Am Coll Cardiol. 1988;11(2):297–307. doi: 10.1016/0735-1097(88)90094-0
   PubMed Web of Science ®Google Scholar
• Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol. 2006; 84(2):115–124. doi: 10.1111/j.1440-1711.2005.01407.x
   PubMed Web of Science ®Google Scholar
• Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease. Circulation. 1998; 97(9):916–931. doi: 10.1161/01.CIR.97.9.916
   PubMed Web of Science ®Google Scholar
• Souza DSR, Dashwood MR, Tsui JCS, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73(4):1189–1195. doi: 10.1016/s0003-4975(02)03425-2
   PubMed Web of Science ®Google Scholar
• Tsui JCS, Souza D, Filbey D, et al. Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel “no-touch” technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg. 2002;35(2):356–362. doi: 10.1067/mva.2002.121072
   PubMed Web of Science ®Google Scholar
• Kim MS, Hwang HY, Kim JS, et al. Saphenous vein versus right internal thoracic artery as a Y-composite graft: Five-year angiographic and clinical results of a randomized trial. J Thorac Cardiovasc Surg. 2018;156(4):1424–1433.e1. doi: 10.1016/j.jtcvs.2018.04.123
   PubMed Web of Science ®Google Scholar
• Hage A, Voisine P, Erthal F, et al. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial. J Thorac Cardiovasc Surg. 2018;155(1):212–222.e2. doi: 10.1016/j.jtcvs.2017.06.039
   PubMed Web of Science ®Google Scholar
• Roth JA, Cukingnan RA, Brown BG, et al. Factors influencing patency of saphenous vein grafts. Ann Thorac Surg. 1979;28(2):176–183. doi: 10.1016/s0003-4975(10)63777-0
   PubMed Web of Science ®Google Scholar
• Widimsky P, Straka Z, Stros P, et al. One-year coronary bypass graft patency. Circulation. 2004;110(22):3418–3423. doi: 10.1161/01.CIR.0000148139.79580.36
   PubMed Web of Science ®Google Scholar
• Botman CJ, Schonberger J, Koolen S, et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg. 2007;83(6):2093–2097. doi: 10.1016/j.athoracsur.2007.01.027
   PubMed Web of Science ®Google Scholar
• Zenati MA, Shroyer AL, Collins JF, et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On/Off Bypass) trial. J Thorac Cardiovasc Surg. 2011;141(2):338–344. doi: 10.1016/j.jtcvs.2010.10.004
   PubMed Web of Science ®Google Scholar
• Lopes RD, Hafley GE, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009;361(3):235–244. doi: 10.1056/NEJMoa0900708
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165. doi: 10.1093/eurheartj/ehy394
   PubMed Web of Science ®Google Scholar
• Paterson HS, Bannon PG, Taggart DP. Competitive flow in coronary bypass surgery: The roles of fractional flow reserve and arterial graft configuration. J Thorac Cardiovasc Surg. 2017;154(5):1570–1575. doi: 10.1016/j.jtcvs.2017.05.087
   PubMed Web of Science ®Google Scholar
• Toth G, De Bruyne B, Casselman F, et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation. Accessed Mar 10, 2023. https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.113.002740
   Google Scholar
• Toth GG, De Bruyne B, Kala P, et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2019;15(11):e999–e1005. doi: 10.4244/EIJ-D-19-00463
   Google Scholar
• Mehta RH, Ferguson TB, Lopes RD, et al. Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery. Circulation. 124(3):280-288, 2011. Accessed Mar 10, 2023. https://www.ahajournals.org/doi/10.1161/circulationaha.110.991299
   Google Scholar
• Li J, Liu Y, Zheng J, et al. The patency of sequential and individual vein coronary bypass grafts: a systematic review. Ann Thorac Surg. 2011;92(4):1292–1298. doi: 10.1016/j.athoracsur.2011.05.038
   PubMed Web of Science ®Google Scholar
• American College of Cardiology: Latest in cardiology. Willemsen L, Janssen P, Klein P, et al. Therapies to improve vein graft patency after CABG. Accessed Feb. 25, 2023. Accessed from: https://www.acc.org/Latest-in-Cardiology/Articles/2021/02/08/19/04/Therapies-to-Improve-Vein-Graft-Patency-After-CABG
   Google Scholar
• Kim KB, Hwang HY, Hahn S, et al. A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: one-year angiographic results and mid-term clinical outcomes. J Thorac Cardiovasc Surg. 2014;148(3):901–907. discussion 907-908. doi: 10.1016/j.jtcvs.2014.03.057
   PubMed Web of Science ®Google Scholar
• Samano N, Geijer H, Liden M, et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. J Thorac Cardiovasc Surg. 2015;150(4):880–888. doi: 10.1016/j.jtcvs.2015.07.027
   PubMed Web of Science ®Google Scholar
• Hattler B, Messenger JC, Shroyer AL, et al. Off-pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft patency and less effective revascularization. Circulation 2012; 125(23):2827-2835. Accessed Mar 10, 2023. https://www.ahajournals.org/doi/10.1161/circulationaha.111.069260
   Google Scholar
• Harskamp RE, Alexander JH, Schulte PJ, et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 2014;149(8):798–805. doi: 10.1001/jamasurg.2014.87
   PubMed Web of Science ®Google Scholar
• Niclauss L. Techniques and standards in intraoperative graft verification by transit time flow measurement after coronary artery bypass graft surgery: a critical review. Eur J Cardio-Thorac Surg. 2017; 51(1):26–33. doi: 10.1093/ejcts/ezw203
   PubMed Web of Science ®Google Scholar
• Ben-Gal Y, Taggart DP, Williams MR, et al. Expandable external support device to improve saphenous vein graft patency after CABG. J Cardiothorac Surg. 2013;8(1):122. doi: 10.1186/1749-8090-8-122
   PubMedGoogle Scholar
• Goldstein DJ, Puskas JD, Alexander JH, et al. External support for saphenous vein grafts in coronary artery bypass surgery: a randomized clinical trial. JAMA Cardiol. 2022;7(8):808–816. doi: 10.1001/jamacardio.2022.1437
   PubMed Web of Science ®Google Scholar
• Taggart DP, Webb CM, Desouza A, et al. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial. J Cardiothorac Surg. 2018;13(1):117. doi: 10.1186/s13019-018-0803-9
   PubMedGoogle Scholar
• Solymoss BC, Nadeau P, Millette D, et al. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation. 1988;78(3 Pt2):I140-143. PMID 3261650.
   Google Scholar
• Kugiyama K, Sakamoto T, Misumi I, et al. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res. 1993;73(2):335–343. doi: 10.1161/01.res.73.2.335
   PubMed Web of Science ®Google Scholar
• Brunkwall JS, Bergqvist D. Prostacyclin release from the human saphenous vein in diabetics is lower than in nondiabetics. World J Surg. 1992;16(6):1141–1145. discussion 1146. doi: 10.1007/BF02067081
   PubMed Web of Science ®Google Scholar
• Kulik A, Abreu AM, Boronat V, et al. Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: the aggressive cholesterol therapy to inhibit vein graft events randomized clinical trial. J Thorac Cardiovasc Surg. 2019;157(1):151–161.e1. doi: 10.1016/j.jtcvs.2018.05.123
   PubMed Web of Science ®Google Scholar
• Eisen A, Cannon CP, Blazing MA, et al. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. Eur Heart J. 2016;37(48):3576–3584. doi: 10.1093/eurheartj/ehw377
   PubMed Web of Science ®Google Scholar
• Zimmermann N, Gams E, Hohlfeld T. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur J Cardio-Thorac Surg. 2008;34(1):93–108. doi: 10.1016/j.ejcts.2008.03.023
   PubMed Web of Science ®Google Scholar
• Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC), the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Windecker S, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2014;35(370):2541-619. doi: 10.1093/eurheartj/ehu278
   Google Scholar
• Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145(3):e18–e114. doi: 10.1161/CIR.0000000000001038
   PubMed Web of Science ®Google Scholar
• Kulik A, Ruel M, Jneid H, et al. Secondary prevention after coronary artery bypass graft surgery. Circulation 2015;131(10):927-9264. https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000182
   Google Scholar
• McKavanagh P, Yanagawa B, Zawadowski G, et al. Management and prevention of saphenous vein graft failure: a review. Cardiol Ther. 2017; 6(2):203–223. doi: 10.1007/s40119-017-0094-6
   PubMedGoogle Scholar
• Abdelrahman A, Dębski M, More R, et al. One-year outcomes of percutaneous coronary intervention in native coronary arteries versus saphenous vein grafts in patients with prior coronary artery bypass graft surgery. Cardiol J. 2022;29(3):396–404. doi: 10.5603/CJ.a2020.0131
   PubMed Web of Science ®Google Scholar
• de Winter RW, Walsh SJ, Hanratty CG, et al. Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: rationale and design of the multicenter, randomized PROCTOR trial. Am Heart J. 2023;257:20–29. doi: 10.1016/j.ahj.2022.11.014
   PubMed Web of Science ®Google Scholar
• Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. saphenous vein de novo trial investigators. N Engl J Med. 1997;337(11):740–747. doi: 10.1056/NEJM199709113371103
   PubMed Web of Science ®Google Scholar
• Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105(11):1285–1290. doi: 10.1161/01.CIR.0000012783.63093.0C
   PubMed Web of Science ®Google Scholar
• Paul TK, Bhatheja S, Panchal HB, et al. Outcomes of saphenous vein graft intervention with and without embolic protection device: a comprehensive review and meta-analysis. Circ Cardiovasc Interv. 2017;10(12):e005538. doi: 10.1161/CIRCINTERVENTIONS.117.005538
   PubMed Web of Science ®Google Scholar
• Harskamp RE, Beijk MA, Damman P, et al. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure. J Cardiovasc Med 2013;14(6):438–445. doi: 10.2459/JCM.0b013e328356a4fc
   Google Scholar
• Sabik JF, Blackstone EH, Houghtaling PL, et al. Is reoperation still a risk factor in coronary artery bypass surgery? Ann Thorac Surg. 2005;80(5):1719–1727. doi: 10.1016/j.athoracsur.2005.04.033
   PubMed Web of Science ®Google Scholar
• Kindzelski BA, Bakaeen FG, Tong MZ, et al. Modern practice and outcomes of reoperative cardiac surgery. J Thorac Cardiovasc Surg. 2022;164(6):1755–1766.e16. doi: 10.1016/j.jtcvs.2021.01.028
   PubMed Web of Science ®Google Scholar